ACM
DAWN

Aster Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Aster Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-651
Closed -$6.07K – 961
2025
Q4 		$6.07K Buy
+651
New +$5.44K ﹤0.01% 840
2025
Q2 		– Sell
-986
Closed -$8.93K – 1156
2025
Q1 		$8.93K Buy
986
+644
+188% +$6.94K ﹤0.01% 1069
2024
Q4 		$4.33K Sell
342
-555
-62% -$7.72K ﹤0.01% 879
2024
Q3 		$12.5K Buy
+897
New +$12.8K ﹤0.01% 759

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Aster Capital Management's DAWN Position: Q1 2026 in Review

Aster Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q1 2026, closing a stake of 651 shares — an estimated $6.07K sold.

Aster Capital Management first reported a position in DAWN in Q3 2024 and held it in 4 quarters. The position peaked at $12.5K in Q3 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Aster Capital Management reported no remaining Day One Biopharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 651 Day One Biopharmaceuticals shares in Q1 2026, an estimated $6.07K.
  • Aster Capital Management first reported a position in Day One Biopharmaceuticals in Q3 2024 and held it in 4 quarters.
  • Aster Capital Management's Day One Biopharmaceuticals position peaked at $12.5K in Q3 2024.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.